18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer

Journal of Nuclear Medicine

Volumn 43, Issue 1, 2002, Pages 39-45

  Higashi, Kotaro ^a   Ueda, Yoshimichi ^a   Arisaka, Yukiko ^a   Sakuma, Tsutomu ^a   Nambu, Yoshihiro ^a   Oguchi, Manabu ^a   Seki, Hiroyasu ^a   Taki, Suzuka ^a   Tonami, Hisao ^a   Yamamoto, Itaru ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

18F FDG; Disease free survival; Lung cancer; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CORRELATION ANALYSIS; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; THORACOTOMY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE FREE SURVIVAL; LUNG; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SCINTISCANNING; SURVIVAL; TUMOR RECURRENCE;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOPHARMACEUTICALS; SURVIVAL ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036007408     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA
2. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma
3. Prognosis and survival in resected lung carcinoma based on the new international staging system
4. Prognostic significance of different biomarkers in non-small cell lung cancer
5. Prognostic significance of the proliferation index in surgically resected non-small-cell lung cancer
6. The interaction among glucose transport, hexokinase, and glucose-6-phosphatase with respect to 3H-2-deoxyglucose retention in murine tumor models
7. FDG PET measurement of the proliferative potential of non-small cell lung cancer
8. Lung tumor growth correlations with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography
9. Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography
10. FDG PET in the evaluation of the aggressiveness of pulmonary adenocarcinoma: Correlation with histopathological features
11. 18F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer
12. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma
13. 18F-fluoro-2-deoxy-glucose- positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases
14. Blood vessel invasion and expression of sialyl Lewis and proliferating cell nuclear antigen in stage I non-small cell lung cancer: Relation to postoperative recurrence
15. Conventional clinicopathologic prognostic factor in surgically resected nonsmall cell lung carcinoma: A comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses
16. Correlation of Glut-1 glucose transporter expression with F-18 FDG uptake in non-small cell carcinoma
17. Overexpression of Glutl and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival
18. Glucose-transporter-type-1-gene amplification correlates with sialyl-Lewis-X synthesis and proliferation in lung cancer
19. SUV: Standard uptake or silly useless value?
20. Fluorine-18-FDG imaging is negative in bronchioloalveolar lung carcinoma
21. Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features
22. The changing pattern of lung carcinoma